P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY

Detalles Bibliográficos
Autores principales: Zheng, Zhong, Zhang, Huilai, Zhou, Keshu, Zhou, Hui, Zhang, LI, LI, Caixia, Zhou, Min, Qian, Wenbin, LI, Zhiming, Zhang, Qingyuan, Cheng, Ying, Peng, Liu, LI, Zhenyu, Su, Liping, LI, Fei, Sun, Xiuhua, Wang, Jingwen, Gao, Yuhuan, Zhao, Xielan, LI, Kunyan, Ding, Kaiyang, Zhu, Zunmin, Wang, Ying, Jing, Hongmei, Xu, Xiaohong, Wang, Xin, Sun, Zimin, Gao, Da, Zhao, Wei-LI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430982/
http://dx.doi.org/10.1097/01.HS9.0000971292.12638.60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430982/
http://dx.doi.org/10.1097/01.HS9.0000971292.12638.60

Ejemplares similares